Misoprostol versus Oxytocin as prophylaxes against intraoperative and postoperative bleeding in cesarean section

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12610001018000

Enrollment

220

Registered

2010-11-22

Start date

2010-12-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To compare the efficacy of rectally administrated Misoprostol vs. intravenous Oxytocin infusion during and after cesarean sections to control intraoperative and postoperative bleeding.

Interventions

600 microgram misoprostol (3 tablets) administrated rectally, right after induction of anesthesia.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Prevention

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

15 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

patients admitted for elective lower segment cesarean section

Exclusion criteria

patients with risk factors for postpartum hemorrhage, emergency lower segment cesarean section, or known hypersensitivity to prostaglandins.

Outcome results